Search Results - "Mehta, Rashmi"

Refine Results
  1. 1

    Characterization of True and False Positive Findings on Contrast-Enhanced Mammography by Phillips, Jordana, U. Achibiri, Janeiro, Kim, Geunwon, Quintana, Liza M., J. Mehta, Rashmi, S. Mehta, Tejas

    Published in Academic radiology (01-11-2022)
    “…The purpose of this paper is to characterize true and false positive findings on contrast-enhanced mammography (CEM) and correlate enhancement pattern and…”
    Get full text
    Journal Article
  2. 2

    Once-Daily Umeclidinium/Vilanterol 125/25 μg Therapy in COPD by Celli, Bartolome, MD, FCCP, Crater, Glenn, MD, FCCP, Kilbride, Sally, MSc, Mehta, Rashmi, PhD, Tabberer, Maggie, MSc, Kalberg, Chris J., PhD, Church, Alison, MD

    Published in Chest (01-05-2014)
    “…Background Combination long-acting bronchodilator therapy may be more effective than long-acting bronchodilator monotherapy in COPD. Our objectives were to…”
    Get full text
    Journal Article
  3. 3

    Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial by Kelleher, Dennis L, Mehta, Rashmi S, Jean-Francois, Bernadette M, Preece, Andrew F, Blowers, James, Crater, Glenn D, Thomas, Paul

    Published in PloS one (17-12-2012)
    “…Umeclidinium bromide (GSK573719; UMEC), a new long-acting muscarinic receptor antagonist (LAMA), is in development with vilanterol (GW642444; VI), a selective…”
    Get full text
    Journal Article
  4. 4

    Impact of imaging nurse navigation on breast interventions: Direct and closed-loop patient communication and documentation by Tannenbaum, Melissa F., Mehta, Tejas S., Phillips, Jordana, Du, Linda, Mehta, Rashmi J., Brook, Alexander

    Published in Clinical imaging (01-09-2023)
    “…A breast imaging nurse navigator (NN) was established with the goals to enhance the patient experience after biopsy, improve care timeliness, accuracy, and…”
    Get full text
    Journal Article
  5. 5

    Reference evapotranspiration (ETo) and crop water requirement (ETc) of wheat and maize in Gujarat by RASHMI MEHTA, VYAS PANDEY

    Published in Journal of agrometeorology (01-06-2015)
    “…The reference evapotranspiration (ETo) is an important agrometeorological parameter which has been used in a number of applications. In present study daily ETo…”
    Get full text
    Journal Article
  6. 6

    Breast Imaging Fellowship Training in the United States: A National Survey of Fellowship Program Directors by Weinstein, Joshua D, Mehta, Rashmi J, Mehta, Tejas S, Kavandi, Hadiseh, Brook, Alexander, Phillips, Jordana

    Published in Journal of breast imaging (30-11-2023)
    “…Abstract Objective To provide an updated characterization of breast imaging fellowship programs in the United States to identify opportunities for improvement…”
    Get full text
    Journal Article
  7. 7

    Contrast-enhanced Mammography: A Guide to Setting Up a New Clinical Program by Kim, Geunwon, Patel, Bhavika, Mehta, Tejas S, Du, Linda, Mehta, Rashmi J, Phillips, Jordana

    Published in Journal of breast imaging (21-05-2021)
    “…Abstract Contrast-enhanced mammography (CEM) is gaining rapid traction following the U.S. Food and Drug Administration approval for diagnostic indications…”
    Get full text
    Journal Article
  8. 8

    Crop water requirement (ETc) of different crops of middle Gujarat by RASHMI MEHTA, VYAS PANDEY

    Published in Journal of agrometeorology (01-06-2016)
    “…Accurate estimation of crop water requirements (ETc) of any crop is essentially required for irrigation scheduling and water management. The present study was…”
    Get full text
    Journal Article
  9. 9

    Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1 by Chandasana, Hardik, van Dijkman, Sven C., Mehta, Rashmi, Bush, Mark, Rabie, Helena, Flynn, Patricia, Cressey, Tim R., Acosta, Edward P., Brooks, Kristina M.

    Published in Infectious diseases and therapy (01-08-2024)
    “…Introduction Once-daily fixed-dose combinations (FDC) containing abacavir (ABC), dolutegravir (DTG), and lamivudine (3TC) have been approved in the US for…”
    Get full text
    Journal Article
  10. 10

    Pharmacokinetics and tolerability of inhaled umeclidinium and vilanterol alone and in combination in healthy Chinese subjects: a randomized, open-label, crossover trial by Hu, Chaoying, Jia, Jingying, Dong, Kelly, Luo, Linda, Wu, Kai, Mehta, Rashmi, Peng, Jack, Ren, Yan, Gross, Annette, Yu, Hui

    Published in PloS one (27-03-2015)
    “…Inhaled umeclidinium (UMEC) and the combination of inhaled UMEC with vilanterol (UMEC/VI) are approved maintenance treatments for chronic obstructive pulmonary…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study by Mehta, Rashmi, Kelleher, Dennis, Preece, Andrew, Hughes, Stephen, Crater, Glenn

    “…The combination of umeclidinium (UMEC), a long-acting muscarinic receptor antagonist, and vilanterol (VI), a selective long-acting β₂ agonist, is in…”
    Get full text
    Journal Article
  14. 14

    A technique to prevent overfilling of viewing chamber of intravenous infusion kit by Kakani, Lovelesh, Sharma, Surinder M, Mehta, Rashmi C, Singh, Gurpreet

    Published in Indian journal of anaesthesia (01-11-2014)
    “…Inflation of the BP cuff on this limb leads to back flow of fluid/blood through the transfusion tubing leading to complete filling of the viewing chamber of…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Umeclidinium in patients with COPD: a randomised, placebo-controlled study by TRIVEDI, Roopa, RICHARD, Nathalie, MEHTA, Rashmi, CHURCH, Alison

    Published in The European respiratory journal (2014)
    “…Efficacy and safety of umeclidinium administered in a dry power inhaler were evaluated in moderate-to-very-severe chronic obstructive pulmonary disease…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Population Dose–Response‐Time Analysis of Itch Reduction and Patient‐Reported Tolerability Supports Phase III Dose Selection for Linerixibat by Carreño, Fernando, Karatza, Eleni, Mehta, Rashmi, Collins, Jon, Austin, Daren, Swift, Brandon

    Published in Clinical pharmacology and therapeutics (01-02-2024)
    “…Increase in serum bile acids (BAs) in patients with primary biliary cholangitis (PBC) may play a causal role in cholestatic pruritus (itch). Linerixibat is a…”
    Get full text
    Journal Article
  20. 20

    Integrated Population Exposure–Response of Dolutegravir in HIV‐1 Supports Bridging of Clinical Response Influenced by Relevant Intrinsic and Extrinsic Patient Characteristics by Chandasana, Hardik, Bush, Mark, Vavro, Cindy, Huang, Jenny, Ait‐Khaled, Mounir, Wynne, Brian, Min, Sherene, Mehta, Rashmi

    Published in Clinical pharmacology and therapeutics (01-10-2024)
    “…Dolutegravir (DTG) is a human immunodeficiency virus type 1 (HIV‐1) integrase strand transfer inhibitor indicated in combination with other antiretroviral…”
    Get full text
    Journal Article